Randomized clinical trial of low dose suramin intravenous infusions for treatment of autism spectrum disorder

Randomized clinical trial of low dose suramin intravenous infusions for treatment of autism spectrum disorder

Abstract Background There is a critical need for effective treatment of the core symptoms of autism spectrum disorder (ASD). The purinergic antagonist suramin may improve core symptoms through restoration of normal mitochondrial function and reduction of neuro-inflammation via its known antagonism o...

Full description

Bibliographic Details
Main Authors: David Hough, Alice R. Mao, Michael Aman, Reymundo Lozano, Constance Smith-Hicks, Veronica Martinez-Cerdeno, Michael Derby, Zachary Rome, Niel Malan, Robert L. Findling
Format: Article
Language:English
Published: BMC 2023-11-01
Series:Annals of General Psychiatry
Subjects:
Autism spectrum disorder
Suramin
Purinergic receptor antagonist
Online Access:https://doi.org/10.1186/s12991-023-00477-8

Internet

https://doi.org/10.1186/s12991-023-00477-8

Similar Items